M&A Deal Summary

Becton Dickinson Acquires Cytognos

On February 1, 2022, Becton Dickinson acquired life science company Cytognos from Vitro Group

Acquisition Highlights
  • This is Becton Dickinson’s 7th transaction in the Life Science sector.
  • This is Becton Dickinson’s 1st transaction in Spain.

M&A Deal Summary

Date 2022-02-01
Target Cytognos
Sector Life Science
Buyer(s) Becton Dickinson
Sellers(s) Vitro Group
Deal Type Divestiture

Target

Cytognos

Salamanca, Spain
Cytognos is a biotechnology company dedicated to the design and development of new reagents, software, and techniques that provide innovative solutions in the flow cytometry field. Cytognos was founded in 1996 and is based in Salamanca, Spain.

Search 205,705 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Becton Dickinson

Franklin Lake, New Jersey, United States

Category Company
Founded 1897
Sector Medical Products
Employees70,000
Revenue 20.2B USD (2024)
DESCRIPTION

Becton Dickinson is a global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. Becton Dickinson was incorporated in 1897 and is headquartered in Franklin Lake, New Jersey.


DEAL STATS #
Overall 26 of 30
Sector (Life Science) 7 of 7
Type (Divestiture) 2 of 3
Country (Spain) 1 of 1
Year (2022) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-09 Tissuemed

Leeds, United Kingdom

Tissuemed is focused on developing self-adhesive surgical sealant film. The company's lead product, Tissuepatch, is a proprietary sealant technology that bonds to tissue to help control internal bleeding or prevent leaks from surgical incisions. The technology's thin, flexible and transparent composition that is ready to use out of the package makes it ideally suited for a range of surgical sealant applications. Tissuemed is based in Leeds, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-06 Parata

Durham, North Carolina, United States

Parata provides pharmacy technology solutions to reduce costs, enhance patient safety and improve the patient experience by offering a comprehensive pharmacy automation portfolio with medication adherence packaging, high-speed robotic dispensing technologies, and pharmacy workflow solutions. Parata is based in Durham, North Carolina.

Buy $1.5B

Seller(S) 1

SELLER

Vitro Group

Sevilla, Spain

Category Company
Founded 1989
Sector Life Science
DESCRIPTION

Vitro Group is a group of biotechnology companies committed to progress in the diagnosis and research in health sciences through the discovery and development of new reagents, software and techniques that provide innovative solutions. Vitro, S.A is one of the first companies in our country in the field of diagnostic and related services: Pathology, Molecular Biology, Cytometry, Clinical Chemistry, Computer applications for the health field and laboratory instruments for clinical laboratory .


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (Spain) 1 of 1
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-07-27 Cytognos

Salamanca, Spain

Cytognos is a biotechnology company dedicated to the design and development of new reagents, software, and techniques that provide innovative solutions in the flow cytometry field. Cytognos was founded in 1996 and is based in Salamanca, Spain.

Buy -